Detalhe da pesquisa
1.
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design.
J Med Genet
; 47(12): 856-8, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20837492
2.
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients.
Eur J Hum Genet
; 13(2): 256-9, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15523494
3.
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy.
Eur J Hum Genet
; 12(1): 59-65, 2004 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-14560316
4.
Pilot trial of phenylbutyrate in spinal muscular atrophy.
Neuromuscul Disord
; 14(2): 130-5, 2004 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-14733959
5.
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study.
Eur J Hum Genet
; 21(6): 630-6, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23073312
6.
Argl6gly polymorphism of the beta2-adrenoceptor gene (ADRBeta2) as a susceptibility factor for nasal polyposis.
Am J Rhinol
; 21(3): 378-82, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17621827